Prevalence of Hepatitis C Screening, Testing, and Care Experience Among Young Adults Who Use Prescription Opioids Nonmedically



      Examine the prevalence of hepatitis C virus (HCV) screening, confirmatory testing, and care experiences among young adult nonmedical prescription opioid (NMPO) users.


      We examined self-reported HCV screening history in a sample of 18- to 29-year-olds reporting past-month NMPO use, and we used modified Poisson regression to identify associated sociodemographic and drug use patterns.


      Among 196 participants, 154 (78.6%) reported prior HCV screening, among whom 18 (11.7%) reported positive results. Of these, 13 (72.2%) reported receiving a confirmatory test; 12 (66.7%) were referred for specialty HCV care. Screening was associated with injection drug use (adjusted prevalence ratio [APR] = 1.19; 95% confidence interval [CI] = 1.05–1.33) and history of hospitalization for psychiatric illness (APR = 1.23; 95% CI = 1.09–1.39). Younger participants (18–23 years) were less likely to have been screened (APR = .69; 95% CI = .57–.85).


      Among young adult NMPO users, post-HCV screening support and referral to care were inadequate.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Adolescent Health
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Valdiserri R.
        • Khalsa J.
        • Dan C.
        • et al.
        Confronting the emerging epidemic of HCV infection among young injection drug users.
        Am J Public Health. 2014; 104: 816-821
        • Klevens R.M.
        • Hu D.J.
        • Jiles R.
        • et al.
        Evolving epidemiology of hepatitis C virus in the United States.
        Clin Infect Dis. 2012; 55: S3-S9
        • Zibbell J.E.
        • Iqbal K.
        • Patel R.
        • et al.
        Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years-Kentucky, Tennessee, Virginia, and West Virginia, 2006–2012.
        MMWR Morb Mortal Wkly Rep. 2015; 64: 453-458
        • Martin N.K.
        • Vickerman P.
        • Grebely J.
        • et al.
        Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals.
        Hepatology. 2013; 58: 1598-1609
        • Evans T.I.
        • Hadland S.E.
        • Clark M.A.
        • et al.
        Factors associated with knowledge of a Good Samaritan Law among young adults who use prescription opioids non-medically.
        Harm Reduct J. 2016; 13: 24
        • Voon P.
        • Kerr T.
        “Nonmedical” prescription opioid use in North America: A call for priority action.
        Subst Abuse Treat Prev Policy. 2013; 8: 39
        • Grebely J.
        • Oser M.
        • Taylor L.E.
        • et al.
        Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: Action required at the system, provider, and patient levels.
        J Infect Dis. 2013; 207: S19-S25
        • Mehta S.H.
        • Genberg B.L.
        • Astemborski J.
        • et al.
        Limited uptake of hepatitis C treatment among injection drug users.
        J Community Health. 2008; 33: 126-133
        • Coyle C.
        • Kwakwa H.
        • Viner K.
        Integrating routine HCV testing in primary care: Lessons learned from five federally qualified health centers in Philadelphia, Pennsylvania, 2012–2014.
        Public Health Rep. 2016; 131: 65-73
        • Trooskin S.B.
        • Poceta J.
        • Towey C.M.
        • et al.
        Results from a geographically focused, community-based HCV screening, linkage-to-care and patient navigation program.
        J Gen Intern Med. 2015; 30: 950-957